Table 3.
Antioxidant, angiotensin converting enzyme (ACE) inhibitory, and antibacterial properties of hydrolysates and fractions with <3.0 kDa molecules.
| Sample | Properties (IC50 ug mL−1) | Antibacterial Activity (L. monocytogenes ATCC BBA-2660) |
|||
|---|---|---|---|---|---|
| ABTS·+ | DPPH· | Fe2+ Chelation | ACE | MIC | |
| Hyrolysates | |||||
| CW | 67.22 ± 1.78 a | 404.26 ± 3.18 a | 0.58 ± 0.03 a | 163.93 ± 1.25 a | 0.25 * |
| M 1 | 80.08 ± 1.99 b | 287.23 ± 2.41 b | 0.62 ± 0.01 a | 205.76 ± 1.57 b | 0.50 * |
| M 2 | 101.54 ± 2.15 c | 198.09 ± 1.18 c | 0.49 ± 0.01 b | 155.76 ± 2.08 c | 0.50 * |
| M 3 | 113.34 ± 1.06 d | 191.04 ± 2.83 d | 0.46 ± 0.02 b | 157.73 ± 1.69 c | 0.50 * |
| Fractions <3.0 kDa | |||||
| CW | 26.67 ± 0.73 a | 31.71 ± 0.98 a | 0.32 ± 0.01 ab | 21.11 ± 0.77 a | 75 ** |
| M 1 | 62.58 ± 1.13 b | 129.45 ± 1.01 b | 0.33 ± 0.02 ab | 24.17 ± 0.51 b | - |
| M 2 | 39.42 ± 1.08 c | 227.01 ± 1.58 c | 0.31 ± 0.02 a | 15.67 ± 1.03 c | 75 ** |
| M 3 | 41.50 ± 2.014 d | 3.46 ± 0.14 d | 0.26 ± 0.01 c | 16.27 ± 0.89 c | 150 ** |
MIC, minimum inhibitory concentration; * mg mL−1, ** µg mL−1; All values are mean ± standard deviation for triplicate experiments. Different letters indicate significant differences (α = 0.05).